Quick Answer
Decoy Therapeutics Inc. reported Common Stock Shares Outstanding of 1.44 million shares for the year ending 2024.
- Decoy Therapeutics Inc. showed an increase of +192.7% in Common Stock Shares Outstanding from 2023 to 2024.
- This data is from Decoy Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 21, 2025.
- XBRL data for this metric is available from 2014 to 2024 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: 14.93 million shares | Q2 2015: 15.19 million shares | Q3 2015: 15.45 million shares | Q1 2016: 16.00 million shares | Q2 2016: 16.26 million shares | Q3 2016: 16.52 million shares | Q1 2017: 17.03 million shares | Q2 2017: 17.29 million shares | Q3 2017: 17.54 million shares | Q1 2018: 17.98 million shares | Q2 2018: 18.07 million shares | Q3 2018: 18.07 million shares | Q1 2019: 18.07 million shares | Q2 2019: 18.07 million shares | Q3 2019: 3.76 million shares | Q2 2020: 14.64 million shares | Q3 2020: 19.82 million shares | Q1 2021: 44.73 million shares | Q2 2021: 44.78 million shares | Q3 2021: 45.17 million shares | Q1 2022: 46.70 million shares | Q2 2022: 56.12 million shares | Q3 2022: 2.25 million shares | Q1 2023: 2.47 million shares | Q2 2023: 3.35 million shares | Q3 2023: 3.94 million shares | Q1 2024: 4.31 million shares | Q2 2024: 641,177 shares | Q3 2024: 1.44 million shares | Q4 2024: 96,077 shares | Q1 2025: 2.08 million shares | Q2 2025: 2.13 million shares | Q3 2025: 944,491 shares.
- Over the full 11 years of available data (2014 to 2024), Decoy Therapeutics Inc.'s Common Stock Shares Outstanding has declined by 35.0%.
- Historical annual values: Fiscal year 2024: 1.44 million shares | Fiscal year 2023: 492,304 shares | Fiscal year 2022: 2.26 million shares | Fiscal year 2021: 1.81 million shares | Fiscal year 2020: 23.81 million shares | Fiscal year 2019: 4.51 million shares | Fiscal year 2018: 2.03 million shares | Fiscal year 2017: 17.80 million shares | Fiscal year 2016: 16.77 million shares | Fiscal year 2015: 15.74 million shares | Fiscal year 2014: 2.22 million shares.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: